Results support advancing LB-102 to Phase 3 clinical development in schizophrenia . NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

The U.K. competition regulator said it could approve Synopsys’s $35 billion purchase of Ansys after the companies offered to ...

The giant batteries will operate for two hours at a time before being depleted. Work on the first phase started in November ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

First Tee Northern Nevada broke ground Monday on the nextchapter for Wildcreek Golf Course, which includes a new golf and ...

Employee residents are ‘Weavers’ and corporations are ‘Inventors’ in the new village near Mount Fuji.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Rising Telegram game Zoo tasks players with creating their own animal amusement park—while earning towards an upcoming crypto ...